Role of the gut microbiome in Uremia: A potential therapeutic target

American Journal of Kidney Diseases

Volumn 67, Issue 3, 2016, Pages 483-498

  Ramezani, Ali ^a   Massy, Ziad A ^b,c   Meijers, Björn ^d   Evenepoel, Pieter ^d   Vanholder, Raymond ^e   Raj, Dominic S ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b HÔPITAL AMBROISE PARÉ   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMINO ACID; AMMONIA; INDOLE DERIVATIVE; PHENOL DERIVATIVE; PROTEIN; SHORT CHAIN FATTY ACID; THIOL DERIVATIVE; UREMIC TOXIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CASE REPORT; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DYSBIOSIS; FERMENTATION; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; MALE; NONHUMAN; PROTEIN CALORIE MALNUTRITION; SYMBIOSIS; SYSTEMIC CIRCULATION; UREMIA; COMPLICATION; EARLY INTERVENTION; METABOLISM; PHYSIOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC;

DISEASE PROGRESSION; DYSBIOSIS; EARLY MEDICAL INTERVENTION; GASTROINTESTINAL MICROBIOME; HUMANS; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 84959044041     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.09.027     Document Type: Article

References (161)

1. J. Qin, R. Li, J. Raes, and et al. A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 7285 2010 59 65
2. D. Gevers, R. Knight, J.F. Petrosino, and et al. The Human Microbiome Project: a community resource for the healthy human microbiome PLoS Biol 10 8 2012 e1001377
3. F. Backhed, R.E. Ley, J.L. Sonnenburg, D.A. Peterson, and J.I. Gordon Host-bacterial mutualism in the human intestine Science 307 5717 2005 1915 1920
4. J. Lederberg Infectious history Science 288 5464 2000 287 293
5. J.A. Hawrelak, and S.P. Myers The causes of intestinal dysbiosis: a review Altern Med Rev 9 2 2004 180 197
6. F. Backhed, H. Ding, T. Wang, and et al. The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 44 2004 15718 15723
7. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 7122 2006 1027 1031
8. W.H. Tang, Z. Wang, B.S. Levison, and et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk N Engl J Med 368 17 2013 1575 1584
9. L.V. Hooper, T. Midtvedt, and J.I. Gordon How host-microbial interactions shape the nutrient environment of the mammalian intestine Annu Rev Nutr 22 2002 283 307
10. M.J. Hill Intestinal flora and endogenous vitamin synthesis Eur J Cancer Prev 6 suppl 1 1997 S43 S45
11. P.B. Hylemon, and J. Harder Biotransformation of monoterpenes, bile acids, and other isoprenoids in anaerobic ecosystems FEMS Microbiol Rev 22 5 1998 475 488
12. S.H. Duncan, A.J. Richardson, P. Kaul, R.P. Holmes, M.J. Allison, and C.S. Stewart Oxalobacter formigenes and its potential role in human health Appl Environ Microbiol 68 8 2002 3841 3847
13. C. Braun-Fahrlander, J. Riedler, U. Herz, and et al. Environmental exposure to endotoxin and its relation to asthma in school-age children N Engl J Med 347 12 2002 869 877
14. J. Xu, and J.I. Gordon Honor thy symbionts Proc Natl Acad Sci U S A 100 18 2003 10452 10459
15. The Human Microbiome Project consortium A framework for human microbiome research Nature 486 7402 2012 215 221
16. The Human Microbiome Project consortium Structure, function and diversity of the healthy human microbiome Nature 486 7402 2012 207 214
17. P.B. Eckburg, E.M. Bik, C.N. Bernstein, and et al. Diversity of the human intestinal microbial flora Science 308 5728 2005 1635 1638
18. V. Tremaroli, and F. Backhed Functional interactions between the gut microbiota and host metabolism Nature 489 7415 2012 242 249
19. T. Yatsunenko, F.E. Rey, M.J. Manary, and et al. Human gut microbiome viewed across age and geography Nature 486 7402 2012 222 227
20. B.D. Muegge, J. Kuczynski, D. Knights, and et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans Science 332 6032 2011 970 974
21. E. Metchnikoff Essais optimistes Chalmers Mitchell P, transl, ed. Paris. The Prolongation of Life: Optimistic Studies 1907 Heinemann London 73 83
22. A. Ramezani, and D.S. Raj The gut microbiome, kidney disease, and targeted interventions J Am Soc Nephrol 25 4 2014 657 670
23. N.D. Vaziri, J. Wong, M. Pahl, and et al. Chronic kidney disease alters intestinal microbial flora Kidney Int 83 2 2013 308 315
24. M. Hida, Y. Aiba, S. Sawamura, N. Suzuki, T. Satoh, and Y. Koga Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis Nephron 74 2 1996 349 355
25. M.J. Wu, C.S. Chang, C.H. Cheng, and et al. Colonic transit time in long-term dialysis patients Am J Kidney Dis 44 2 2004 322 327
26. B. Bammens, K. Verbeke, Y. Vanrenterghem, and P. Evenepoel Evidence for impaired assimilation of protein in chronic renal failure Kidney Int 64 6 2003 2196 2203
27. V.M. Krishnamurthy, G. Wei, B.C. Baird, and et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease Kidney Int 81 3 2012 300 306
28. C. Wandersman, and P. Delepelaire Bacterial iron sources: from siderophores to hemophores Annu Rev Microbiol 58 2004 611 647
29. C. Jernberg, S. Lofmark, C. Edlund, and J.K. Jansson Long-term impacts of antibiotic exposure on the human intestinal microbiota Microbiology 156 pt 11 2010 3216 3223
30. L. Dethlefsen, and D.A. Relman Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation Proc Natl Acad Sci U S A 108 suppl 1 2011 4554 4561
31. L. Dethlefsen, S. Huse, M.L. Sogin, and D.A. Relman The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing PLoS Biol 6 11 2008 e280
32. A. Einheber, and D. Carter The role of the microbial flora in uremia. I. Survival times of germfree, limited-flora, and conventionalized rats after bilateral nephrectomy and fasting J Exp Med 123 2 1966 239 250
33. P.A. Aronov, F.J. Luo, N.S. Plummer, and et al. Colonic contribution to uremic solutes J Am Soc Nephrol 22 9 2011 1769 1776
34. W.R. Wikoff, A.T. Anfora, J. Liu, and et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc Natl Acad Sci U S A 106 10 2009 3698 3703
35. L.B. Sorensen Role of the intestinal tract in the elimination of uric acid Arthritis Rheum 8 5 1965 694 706
36. S.A. Gibson, C. McFarlan, S. Hay, and G.T. Macfarlane Significance of microflora in proteolysis in the colon Appl Environ Microbiol 55 3 1989 679 683
37. M. Walser, and L.J. Bodenlos Urea metabolism in man J Clin Invest 38 1959 1617 1626
38. G.S. Stewart, and C.P. Smith Urea nitrogen salvage mechanisms and their relevance to ruminants, non-ruminants and man Nutr Res Rev 18 1 2005 49 62
39. N.D. Vaziri, J. Yuan, A. Rahimi, Z. Ni, H. Said, and V.S. Subramanian Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation Nephrol Dial Transplant 27 7 2012 2686 2693
40. N.D. Vaziri, N. Goshtasbi, J. Yuan, and et al. Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium Am J Nephrol 36 5 2012 438 443
41. N.D. Vaziri, J. Yuan, and K. Norris Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease Am J Nephrol 37 1 2013 1 6
42. J.D. Jones, and P.C. Burnett Creatinine metabolism in humans with decreased renal function: creatinine deficit Clin Chem 20 9 1974 1204 1212
43. H.G. Van Eyk, R.J. Vermaat, H.J. Leijnse-Ybema, and B. Leijnse The conversion of creatinine by creatiniase of bacterial origin Enzymologia 34 1986 198 202
44. N.S. Olsen, and J.W. Bassett Blood levels of urea nitrogen, phenol, guanidine and creatinine in uremia Am J Med 10 1 1951 52 59
45. T. Yokozawa, Z.L. Mo, and H. Oura Comparison of toxic effects of methylguanidine, guanidinosuccinic acid and creatinine in rats with adenine-induced chronic renal failure Nephron 51 3 1989 388 392
46. M.H. Alderman, H. Cohen, S. Madhavan, and S. Kivlighn Serum uric acid and cardiovascular events in successfully treated hypertensive patients Hypertension 34 1 1999 144 150
47. T. Gibson, J. Highton, C. Potter, and H.A. Simmonds Renal impairment and gout Ann Rheum Dis 39 5 1980 417 423
48. M. Hatch, and N.D. Vaziri Enhanced enteric excretion of urate in rats with chronic renal failure Clin Sci (Lond) 86 5 1994 511 516
49. J. Wong, Y.M. Piceno, T.Z. Desantis, M. Pahl, G.L. Andersen, and N.D. Vaziri Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD Am J Nephrol 39 3 2014 230 237
50. P.M. van Haard Chromatography of urinary indole derivatives J Chromatogr 429 1988 59 94
51. C.J. Lin, H.H. Chen, C.F. Pan, and et al. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease J Clin Lab Anal 25 3 2011 191 197
52. I.W. Wu, K.H. Hsu, C.C. Lee, and et al. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease Nephrol Dial Transplant 26 3 2011 938 947
53. M. Motojima, A. Hosokawa, H. Yamato, T. Muraki, and T. Yoshioka Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake Br J Pharmacol 135 2 2002 555 563
54. M. Motojima, A. Hosokawa, H. Yamato, T. Muraki, and T. Yoshioka Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells Kidney Int 63 5 2003 1671 1680
55. M.J. Lysaght, E.F. Vonesh, F. Gotch, and et al. The influence of dialysis treatment modality on the decline of remaining renal function ASAIO Trans 37 4 1991 598 604
56. T. Miyazaki, M. Ise, H. Seo, and T. Niwa Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys Kidney Int Suppl 62 1997 S15 S22
57. A. Adijiang, Y. Higuchi, F. Nishijima, H. Shimizu, and T. Niwa Indoxyl sulfate, a uremic toxin, promotes cell senescence in aorta of hypertensive rats Biochem Biophys Res Commun 399 4 2010 637 641
58. F.C. Barreto, D.V. Barreto, S. Liabeuf, and et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients Clin J Am Soc Nephrol 4 10 2009 1551 1558
59. H. Yamamoto, S. Tsuruoka, T. Ioka, and et al. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells Kidney Int 69 10 2006 1780 1785
60. L. Dou, N. Jourde-Chiche, V. Faure, and et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells J Thromb Haemost 5 6 2007 1302 1308
61. N. Amabile, A.P. Guerin, A. Leroyer, and et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure J Am Soc Nephrol 16 11 2005 3381 3388
62. L. Dou, E. Bertrand, C. Cerini, and et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair Kidney Int 65 2 2004 442 451
63. C.K. Chiang, T. Tanaka, R. Inagi, T. Fujita, and M. Nangaku Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner Lab Invest 91 11 2011 1564 1571
64. T. Nii-Kono, Y. Iwasaki, M. Uchida, and et al. Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells Kidney Int 71 8 2007 738 743
65. A. Mozar, L. Louvet, C. Godin, and et al. Indoxyl sulphate inhibits osteoclast differentiation and function Nephrol Dial Transplant 27 6 2012 2176 2181
66. F.C. Barreto, D.V. Barreto, M.E. Canziani, and et al. Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients J Bras Nefrol 36 3 2014 289 296
67. O. Ichii, S. Otsuka-Kanazawa, T. Nakamura, and et al. Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand PLoS One 9 9 2014 e108448
68. T. Niwa, N. Takeda, A. Tatematsu, and K. Maeda Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography Clin Chem 34 11 1988 2264 2267
69. A.W. Martinez, N.S. Recht, T.H. Hostetter, and T.W. Meyer Removal of p-cresol sulfate by hemodialysis J Am Soc Nephrol 16 11 2005 3430 3436
70. R. De Smet, A. Dhondt, S. Eloot, F. Galli, M.A. Waterloos, and R. Vanholder Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes Nephrol Dial Transplant 22 7 2007 2006 2012
71. M. Satoh, H. Hayashi, M. Watanabe, and et al. Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure Nephron Exp Nephrol 95 3 2003 e111 e118
72. L. Dou, M. Sallee, C. Cerini, and et al. The cardiovascular effect of the uremic solute indole-3 acetic acid J Am Soc Nephrol 26 4 2015 876 887
73. J.H. Cummings Fermentation in the human large intestine: evidence and implications for health Lancet 1 8335 1983 1206 1209
74. Loor H. de, B. Bammens, P. Evenepoel, V. De Preter, and K. Verbeke Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum Clin Chem 51 8 2005 1535 1538
75. B.K. Meijers, and P. Evenepoel The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression Nephrol Dial Transplant 26 3 2011 759 761
76. H.A. Mutsaers, M.J. Wilmer, L.P. van den Heuvel, J.G. Hoenderop, and R. Masereeuw Basolateral transport of the uraemic toxin p-cresyl sulfate: role for organic anion transporters? Nephrol Dial Transplant 26 12 2011 4149
77. R. Poesen, L. Viaene, K. Verbeke, and et al. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD Clin J Am Soc Nephrol 8 9 2013 1508 1514
78. C.Y. Sun, S.C. Chang, and M.S. Wu Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition PLoS One 7 3 2012 e34026
79. H. Watanabe, Y. Miyamoto, D. Honda, and et al. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase Kidney Int 83 4 2013 582 592
80. B. Bammens, P. Evenepoel, H. Keuleers, K. Verbeke, and Y. Vanrenterghem Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients Kidney Int 69 6 2006 1081 1087
81. S. Liabeuf, D.V. Barreto, F.C. Barreto, and et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease Nephrol Dial Transplant 25 4 2010 1183 1191
82. B.K. Meijers, K. Claes, B. Bammens, and et al. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease Clin J Am Soc Nephrol 5 7 2010 1182 1189
83. L. Koppe, N.J. Pillon, R.E. Vella, and et al. p-Cresyl sulfate promotes insulin resistance associated with CKD J Am Soc Nephrol 24 1 2013 88 99
84. L. Zimmerman, B. Egestad, H. Jornvall, and J. Bergstrom Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients Clin Nephrol 32 3 1989 124 128
85. E.A. Smith, and G.T. Macfarlane Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine Microb Ecol 33 3 1997 180 188
86. J.W. Seakins The determination of urinary phenylacetylglutamine as phenylacetic acid. Studies on its origin in normal subjects and children with cystic fibrosis Clin Chim Acta 35 1 1971 121 131
87. D. Yang, M. Beylot, K.C. Agarwal, M.V. Soloviev, and H. Brunengraber Assay of the human liver citric acid cycle probe phenylacetylglutamine and of phenylacetate in plasma by gas chromatography-mass spectrometry Anal Biochem 212 1 1993 277 282
88. C.P. Sherwin, and S. Kennard Toxicity of phenylacetic acid J Biol Chem 12 1919 259 264
89. S. Schmidt, T.H. Westhoff, P. Krauser, and et al. The uraemic toxin phenylacetic acid impairs macrophage function Nephrol Dial Transplant 23 11 2008 3485 3493
90. S. Schmidt, T.H. Westhoff, P. Krauser, W. Zidek, and M. van der Giet The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells Nephrol Dial Transplant 23 1 2008 65 71
91. S. Yano, T. Yamaguchi, I. Kanazawa, and et al. The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure Nephrol Dial Transplant 22 11 2007 3160 3165
92. T. Remer, and F. Manz Paleolithic diet, sweet potato eaters, and potential renal acid load Am J Clin Nutr 78 4 2003 802 803
93. M. Li, B. Wang, M. Zhang, and et al. Symbiotic gut microbes modulate human metabolic phenotypes Proc Natl Acad Sci U S A 105 6 2008 2117 2122
94. W. Cathcart-Rake, R. Porter, F. Whittier, P. Stein, M. Carey, and J. Grantham Effect of diet on serum accumulation and renal excretion of aryl acids and secretory activity in normal and uremic man Am J Clin Nutr 28 10 1975 1110 1115
95. W.E. Mitch, and S. Brusilow Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure J Pharmacol Exp Ther 222 3 1982 572 575
96. S. Ringoir, R. Vanholder, and Z. Massy Proceedings of the Ghent Symposium on Uremic Toxins Adv Exp Med Biol 223 1986 59 67
97. K. Igarashi, S. Ueda, K. Yoshida, and K. Kashiwagi Polyamines in renal failure Amino Acids 31 4 2006 477 483
98. R.A. Campbell, D.P. Grettie, F. Bartos, D. Bartos, and L.J. Marton Uremic polyamine dysmetabolism Proc Clin Dial Transplant Forum 8 1978 194 198
99. D. Kushner, B. Beckman, L. Nguyen, and et al. Polyamines in the anemia of end-stage renal disease Kidney Int 39 4 1991 725 732
100. H. Bruckner, and M. Hausch Gas chromatographic characterization of free d-amino acids in the blood serum of patients with renal disorders and of healthy volunteers J Chromatogr 614 1 1993 7 17
101. M.S. Oh, K.R. Phelps, M. Traube, J.L. Barbosa-Saldivar, C. Boxhill, and H.J. Carroll d-Lactic acidosis in a man with the short-bowel syndrome N Engl J Med 301 5 1979 249 252
102. Z. Wang, E. Klipfell, B.J. Bennett, and et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 472 7341 2011 57 63
103. R.A. Koeth, Z. Wang, B.S. Levison, and et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis Nat Med 19 5 2013 576 585
104. W.H. Tang, Z. Wang, Y. Fan, and et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis J Am Coll Cardiol 64 18 2014 1908 1914
105. W.H. Tang, Z. Wang, D.J. Kennedy, and et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease Circ Res 116 3 2015 448 455
106. R.J. Reiffenstein, W.C. Hulbert, and S.H. Roth Toxicology of hydrogen sulfide Annu Rev Pharmacol Toxicol 32 1992 109 134
107. 2S)-producing enzymes and capacity in chronic kidney disease Nephrol Dial Transplant 27 2 2012 498 504
108. A.F. Perna, D. Lanza, I. Sepe, and et al. Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it? Blood Purif 31 1-3 2011 102 106
109. A.F. Perna, M.G. Luciano, D. Ingrosso, and et al. Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes Nephrol Dial Transplant 24 12 2009 3756 3763
110. K. Song, F. Wang, Q. Li, and et al. Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy Kidney Int 85 6 2014 1318 1329
111. J. Pugin, I.D. Heumann, A. Tomasz, and et al. CD14 is a pattern recognition receptor Immunity 1 6 1994 509 516
112. M.A. Freudenberg, S. Tchaptchet, S. Keck, and et al. Lipopolysaccharide sensing an important factor in the innate immune response to gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity Immunobiology 213 3-4 2008 193 203
113. J.B. Eggesbo, I. Hjermann, R. Ovstebo, G.B. Joo, and P. Kierulf LPS induced procoagulant activity and plasminogen activator activity in mononuclear cells from persons with high or low levels of HDL lipoprotein Thromb Res 77 5 1995 441 452
114. M.A. Reidy, and D.E. Bowyer Distortion of endothelial repair. The effect of hypercholesterolaemia on regeneration of aortic endothelium following injury by endotoxin. A scanning electron microscope study Atherosclerosis 29 4 1978 459 466
115. R. Poesen, A. Ramezani, K. Claes, and et al. Associations of soluble CD14 and endotoxin with mortality, cardiovascular disease, and progression of kidney disease among patients with CKD Clin J Am Soc Nephrol 10 9 2015 1525 1533
116. D.S. Raj, J.J. Carrero, V.O. Shah, and et al. Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients Am J Kidney Dis 54 6 2009 1072 1080
117. D.S. Raj, V.O. Shah, M. Rambod, C.P. Kovesdy, and K. Kalantar-Zadeh Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis Am J Kidney Dis 54 6 2009 1062 1071
118. P.D. Cani, J. Amar, M.A. Iglesias, and et al. Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 7 2007 1761 1772
119. A.J. Macpherson, and N.L. Harris Interactions between commensal intestinal bacteria and the immune system Nat Rev Immunol 4 6 2004 478 485
120. J.L. Round, and S.K. Mazmanian Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota Proc Natl Acad Sci U S A 107 27 2010 12204 12209
121. T.B. Clarke, K.M. Davis, E.S. Lysenko, A.Y. Zhou, Y. Yu, and J.N. Weiser Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity Nat Med 16 2 2010 228 231
122. B.T. Layden, A.R. Angueira, M. Brodsky, V. Durai, and W.L. Lowe Jr. Short chain fatty acids and their receptors: new metabolic targets Transl Res 161 3 2013 131 140
123. V. Andrade-Oliveira, M.T. Amano, M. Correa-Costa, and et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion J Am Soc Nephrol 26 8 2015 1877 1888
124. I.R. Barrows, A. Ramezani, and D.S. Raj Gut feeling in AKI: the long arm of short-chain fatty acids J Am Soc Nephrol 26 8 2015 1755 1757
125. J.L. Pluznick, R.J. Protzko, H. Gevorgyan, and et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation Proc Natl Acad Sci U S A 110 11 2013 4410 4415
126. R. Vanholder, A. Argiles, U. Baurmeister, and et al. Uremic toxicity: present state of the art Int J Artif Organs 24 10 2001 695 725
127. F. Duranton, G. Cohen, R. De Smit, and et al. Normal and pathologic concentrations of uremic toxins J Am Soc Nephrol 23 7 2012 1258 1270
128. R. Vanholder, J. Boelaert, G. Glorieux, and S. Eloot New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy Semin Dial 28 2 2015 114 124
129. S.G. Tringe, and E.M. Rubin Metagenomics: DNA sequencing of environmental samples Nat Rev Genet 6 11 2005 805 814
130. E.P. Rhee, C.B. Clish, A. Ghorbani, and et al. A combined epidemiologic and metabolomic approach improves CKD prediction J Am Soc Nephrol 24 8 2013 1330 1338
131. H.A. Mutsaers, U.F. Engelke, M.J. Wilmer, and et al. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients PLoS One 8 8 2013 e71199
132. J. Qin, Y. Li, Z. Cai, and et al. A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 490 7418 2012 55 60
133. A. Hevia, C. Milani, P. Lopez, and et al. Intestinal dysbiosis associated with systemic lupus erythematosus MBio 5 5 2014 e01548-14
134. M. De Angelis, E. Montemurno, M. Piccolo, and et al. Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN) PLoS One 9 6 2014 e99006
135. Y. Miyamoto, H. Watanabe, T. Noguchi, and et al. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney Nephrol Dial Transplant 26 8 2011 2498 2502
136. Y. Ando, Y. Miyata, K. Tanba, and et al. [Effect of oral intake of an enteric capsule preparation containing Bifidobacterium longum on the progression of chronic renal failure] Nihon Jinzo Gakkai Shi 45 8 2003 759 764
137. R. Natarajan, B. Pechenyak, U. Vyas, and et al. Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients Biomed Res Int 2014 2014 568571
138. I.K. Wang, Y.Y. Wu, Y.F. Yang, and et al. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial Benef Microbes 6 4 2015 423 430
139. B. Guida, R. Germano, R. Trio, and et al. Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial Nutr Metab Cardiovasc Dis 24 9 2014 1043 1049
140. B.K. Meijers, V. De Preter, K. Verbeke, Y. Vanrenterghem, and P. Evenepoel p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin Nephrol Dial Transplant 25 1 2010 219 224
141. T.L. Sirich, N.S. Plummer, C.D. Gardner, T.H. Hostetter, and T.W. Meyer Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients Clin J Am Soc Nephrol 9 9 2014 1603 1610
142. N.D. Vaziri, S.M. Liu, W.L. Lau, and et al. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease PLoS One 9 12 2014 e114881
143. I. Nakabayashi, M. Nakamura, K. Kawakami, and et al. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study Nephrol Dial Transplant 26 3 2011 1094 1098
144. S. Prakash, and T.M. Chang Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal Biomater Artif Cells Immobilization Biotechnol 21 5 1993 629 636
145. S. Prakash, and T.M. Chang Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats Nat Med 2 8 1996 883 887
146. G. Schulman, R. Agarwal, M. Acharya, T. Berl, S. Blumenthal, and N. Kopyt A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD Am J Kidney Dis 47 4 2006 565 577
147. N.D. Vaziri, J. Yuan, M. Khazaeli, Y. Masuda, H. Ichii, and S. Liu Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption Am J Nephrol 37 6 2013 518 525
148. G. Schulman, T. Berl, G.J. Beck, and et al. Randomized placebo-controlled EPPIC trials of AST-120 in CKD J Am Soc Nephrol 26 7 2015 1732 1746
149. M. Rossi, D.W. Johnson, M. Morrison, and et al. SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial BMC Nephrol 15 2014 106
150. M. Andriamihaja, A. Lan, M. Beaumont, and et al. The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells Free Radic Biol Med 85 2015 219 227
151. H. Strid, M. Simren, P.O. Stotzer, G. Ringstrom, H. Abrahamsson, and E.S. Bjornsson Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth Digestion 67 3 2003 129 137
152. M.L. Simenhoff, S.R. Dunn, G.P. Zollner, and et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus Miner Electrolyte Metab 22 1-3 1996 92 96
153. K. Shi, F. Wang, H. Jiang, and et al. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients Dig Dis Sci 59 9 2014 2109 2117
154. J.B. de Almeida Duarte, J.E. de Aguilar-Nascimento, M. Nascimento, and R.J. Nochi Jr. Bacterial translocation in experimental uremia Urol Res 32 4 2004 266 270
155. N.D. Vaziri, B. Dure-Smith, R. Miller, and M.K. Mirahmadi Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases Am J Gastroenterol 80 8 1985 608 611
156. A.J. Richardson, N. McKain, and R.J. Wallace Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids BMC Microbiol 13 2013 6
157. A.F. Perna, D. Ingrosso, C. Lombardi, and et al. Homocysteine in uremia Am J Kidney Dis 41 3 suppl 1 2003 S123 S126
158. K. Turkmen, and F.M. Erdur The relationship between colonization of Oxalobacter formigenes serum oxalic acid and endothelial dysfunction in hemodialysis patients: from impaired colon to impaired endothelium Med Hypotheses 84 3 2015 273 275
159. C. Cerini, L. Dou, F. Anfosso, and et al. p-Cresol, a uremic retention solute, alters the endothelial barrier function in vitro Thromb Haemost 92 1 2004 140 150
160. P. Evenepoel, B. Bammens, K. Verbeke, and Y. Vanrenterghem Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study Kidney Int 70 1 2006 192 198
161. The effect of arabinoxylan-oligosaccharides (AXOS) on intestinal generation of microbial metabolites in chronic kidney disease. https://clinicaltrials.gov/ct2/show/study/NCT02141815?term=Bj%C3%B6rn+Meijers&rank=4 2015. Accessed August 17, 2015.